DK2938747T3 - Fremgangsmåde til fremstilling af en mycoplasma vaccine - Google Patents

Fremgangsmåde til fremstilling af en mycoplasma vaccine Download PDF

Info

Publication number: DK2938747T3
Authority: DK; Denmark
Prior art keywords: procedure; manufacturing; mycoplasma vaccine; mycoplasma; vaccine
Prior art date: 2012-12-28

Application number

DK13817835.5T

Other languages

English (en)

Inventor

Dianna M Murphy Jordan

Brian Thomas Martinson

Christine Margaret Muehlenthaler

Axel Neubauer

Arun V Iyer

Original Assignee

Boehringer Ingelheim Vetmedica Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-28

Filing date

2013-12-20

Publication date

2019-08-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49917778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2938747(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-20 Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh

2019-08-05 Application granted granted Critical

2019-08-05 Publication of DK2938747T3 publication Critical patent/DK2938747T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/70—Non-animal cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Developmental Biology & Embryology (AREA)
Medicinal Preparation (AREA)

DK13817835.5T 2012-12-28 2013-12-20 Fremgangsmåde til fremstilling af en mycoplasma vaccine DK2938747T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261746997P	2012-12-28	2012-12-28
PCT/US2013/076807 WO2014105672A1 (en)	2012-12-28	2013-12-20	Method of making a mycoplasma vaccine

Publications (1)

Publication Number	Publication Date
DK2938747T3 true DK2938747T3 (da)	2019-08-05

Family

ID=49917778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK13817835.5T DK2938747T3 (da)	2012-12-28	2013-12-20	Fremgangsmåde til fremstilling af en mycoplasma vaccine

Country Status (23)

Country	Link
US (2)	US9273281B2 (da)
EP (1)	EP2938747B1 (da)
JP (2)	JP6122146B2 (da)
KR (1)	KR102153275B1 (da)
CN (2)	CN108379571A (da)
AR (1)	AR094648A1 (da)
AU (1)	AU2013370983B2 (da)
BR (1)	BR112015012711B1 (da)
CA (1)	CA2896298C (da)
CL (1)	CL2015001562A1 (da)
DK (1)	DK2938747T3 (da)
EA (1)	EA032772B1 (da)
ES (1)	ES2738100T3 (da)
HU (1)	HUE045015T2 (da)
MX (2)	MX384875B (da)
MY (1)	MY173223A (da)
PH (1)	PH12015501333B1 (da)
PL (1)	PL2938747T3 (da)
PT (1)	PT2938747T (da)
SG (2)	SG10201708028VA (da)
TW (2)	TWI660736B (da)
UA (1)	UA121193C2 (da)
WO (1)	WO2014105672A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
DK2938747T3 (da)	2012-12-28	2019-08-05	Boehringer Ingelheim Vetmedica Gmbh	Fremgangsmåde til fremstilling af en mycoplasma vaccine
UA121097C2 (uk) *	2012-12-28	2020-04-10	Бьорінгер Інгельхайм Ветмедіка Гмбх	Імуногенна композиція, що містить антигени мікоплазм
CN105441368B (zh) *	2016-01-19	2019-01-01	福清市默克兽医院	一株牛支原体及其应用
EP3408281A4 (en) *	2016-01-29	2019-08-14	Advanced Animal Diagnostics, Inc.	METHOD AND COMPOSITIONS FOR DETECTING MYCOPLASMA EXPOSURE
CN109310113A (zh)	2016-03-22	2019-02-05	先进动物诊断股份有限公司	减少农场动物抗生素施用的方法和组合物
KR102251603B1 (ko) *	2016-08-09	2021-05-14	애그리컬쳐럴 테크놀로지 리서치 인스티튜트	마이코플라즈마 하이오라이니스 감염의 예방 및 치료용 조성물 및 조성물의 생산 방법
WO2018144909A1 (en) *	2017-02-03	2018-08-09	The Administrators Of The Tulane Educational Fund	Ophthalmic compositions for therapeutic and prophylactic uses
EP3632982A1 (en)	2017-05-24	2020-04-08	Mitsubishi Chemical Corporation	Molding material and fiber-reinforced composite material
WO2020251847A1 (en)	2019-06-10	2020-12-17	Elanco Us Inc.	Mycoplasma media formulations
CN113201050B (zh) *	2020-08-06	2022-07-22	青岛诺安百特生物技术有限公司	一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
GB1074920A (en) *	1965-04-21	1967-07-05	Pfizer & Co C	Growth medium for mycoplasma pneumoniae and vaccine production
ES343655A1 (es)	1966-07-11	1968-09-01	Research Corp	Metodo para la preparacion de un inoculo para aves de co- rral.
JPS5540568B2 (da)	1972-10-05	1980-10-18
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en) *	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
EP1260581B1 (en) *	2000-03-03	2010-07-07	Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute	Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
JP3402304B2 (ja) *	2000-03-30	2003-05-06	株式会社微生物化学研究所	猫クラミジアワクチンの製造方法
MY129765A (en)	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en)	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
US20030147914A1 (en)	2001-07-02	2003-08-07	Pfizer Inc.	Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
PT1474067E (pt)	2001-07-02	2008-11-14	Pfizer Prod Inc	Vacinação numa dose com mycoplasma hyopneumoniae
WO2003004051A2 (en)	2001-07-02	2003-01-16	Pfizer Products Inc.	Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
HUP0401077A3 (en)	2001-08-28	2004-10-28	Pfizer Prod Inc	Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
TWI238721B (en) *	2003-06-20	2005-09-01	Animal Technology Inst Taiwan	Swine enzootic vaccine, its producing method and usage
CA2595556A1 (en)	2005-02-09	2006-08-17	Magna International Inc.	Method of manufacturing a semi-structural panel
JP4693839B2 (ja)	2005-03-10	2011-06-01	共立製薬株式会社	動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
WO2007042827A2 (en) *	2005-10-14	2007-04-19	Ivan Petyaev	Treatment and diagnosis of obligate intracellular pathogens
KR101464783B1 (ko)	2006-09-15	2014-11-26	메디뮨 엘엘씨	높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
US20090068231A1 (en)	2007-09-11	2009-03-12	Wyeth	Live attenuated mycoplasma strains
AR069087A1 (es)	2007-10-29	2009-12-30	Boehringer Ingelheim Vetmed	Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
CN104043116A (zh) *	2007-11-06	2014-09-17	硕腾W有限责任公司	猪肺炎支原体无毒力佐剂化活疫苗
JP5613061B2 (ja)	2008-01-23	2014-10-22	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	Ｐｃｖ２マイコプラズマ・ハイオニューモニエ免疫原性組成物および前記組成物の製造方法
US8444989B1 (en)	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
JPWO2009142086A1 (ja)	2008-05-23	2011-09-29	学校法人久留米大学	マイコプラズマ感染症用ワクチン組成物
WO2009156960A2 (en)	2008-06-27	2009-12-30	Pfizer Inc.	Novel adjuvant compositions
EP2362780B1 (en)	2008-10-31	2019-12-25	Boehringer Ingelheim Animal Health USA Inc.	Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
BRPI1010679B1 (pt)	2009-05-19	2020-09-24	Bioproperties Pty Ltd	Cepa de vacina de mycoplasma hyopneumoniae sensível à temperatura e aplicações da mesma, composiçao de vacina, método de preparaçao e uso da mesma
US20110150770A1 (en)	2009-12-18	2011-06-23	Boehringer Ingelheim Vetmedica, Inc.	Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8112663B2 (en)	2010-03-26	2012-02-07	Lsi Corporation	Method to establish redundancy and fault tolerance better than RAID level 6 without using parity
CN102258776B (zh)	2011-07-07	2013-07-10	普莱柯生物工程股份有限公司	猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
DK2938747T3 (da) *	2012-12-28	2019-08-05	Boehringer Ingelheim Vetmedica Gmbh	Fremgangsmåde til fremstilling af en mycoplasma vaccine
UA121097C2 (uk)	2012-12-28	2020-04-10	Бьорінгер Інгельхайм Ветмедіка Гмбх	Імуногенна композиція, що містить антигени мікоплазм

2013
- 2013-12-20 DK DK13817835.5T patent/DK2938747T3/da active
- 2013-12-20 MX MX2018014818A patent/MX384875B/es unknown
- 2013-12-20 AU AU2013370983A patent/AU2013370983B2/en not_active Ceased
- 2013-12-20 CA CA2896298A patent/CA2896298C/en active Active
- 2013-12-20 SG SG10201708028VA patent/SG10201708028VA/en unknown
- 2013-12-20 MY MYPI2015001621A patent/MY173223A/en unknown
- 2013-12-20 PT PT13817835T patent/PT2938747T/pt unknown
- 2013-12-20 PL PL13817835T patent/PL2938747T3/pl unknown
- 2013-12-20 JP JP2015549759A patent/JP6122146B2/ja active Active
- 2013-12-20 HU HUE13817835 patent/HUE045015T2/hu unknown
- 2013-12-20 CN CN201810161003.1A patent/CN108379571A/zh active Pending
- 2013-12-20 US US14/135,796 patent/US9273281B2/en active Active
- 2013-12-20 MX MX2015007730A patent/MX361273B/es active IP Right Grant
- 2013-12-20 KR KR1020157020447A patent/KR102153275B1/ko active Active
- 2013-12-20 PH PH1/2015/501333A patent/PH12015501333B1/en unknown
- 2013-12-20 WO PCT/US2013/076807 patent/WO2014105672A1/en not_active Ceased
- 2013-12-20 BR BR112015012711-8A patent/BR112015012711B1/pt active IP Right Grant
- 2013-12-20 EP EP13817835.5A patent/EP2938747B1/en active Active
- 2013-12-20 ES ES13817835T patent/ES2738100T3/es active Active
- 2013-12-20 UA UAA201507463A patent/UA121193C2/uk unknown
- 2013-12-20 EA EA201500701A patent/EA032772B1/ru not_active IP Right Cessation
- 2013-12-20 SG SG11201505089YA patent/SG11201505089YA/en unknown
- 2013-12-20 CN CN201380066001.XA patent/CN104968365B/zh active Active
- 2013-12-27 AR ARP130105050A patent/AR094648A1/es unknown
- 2013-12-27 TW TW107103700A patent/TWI660736B/zh active
- 2013-12-27 TW TW102148875A patent/TWI618542B/zh active
2015
- 2015-06-05 CL CL2015001562A patent/CL2015001562A1/es unknown
2016
- 2016-01-19 US US15/000,342 patent/US10512680B2/en active Active
2017
- 2017-03-30 JP JP2017067820A patent/JP6449364B2/ja active Active

Also Published As

Publication number	Publication date
SG11201505089YA (en)	2015-07-30
HUE045015T2 (hu)	2019-11-28
AU2013370983A1 (en)	2015-05-21
AR094648A1 (es)	2015-08-19
PL2938747T3 (pl)	2019-11-29
ES2738100T3 (es)	2020-01-20
EA201500701A1 (ru)	2015-12-30
UA121193C2 (uk)	2020-04-27
US20160136254A1 (en)	2016-05-19
SG10201708028VA (en)	2017-10-30
US20140186394A1 (en)	2014-07-03
PT2938747T (pt)	2019-08-01
PH12015501333A1 (en)	2015-09-02
KR20150100920A (ko)	2015-09-02
PH12015501333B1 (en)	2022-10-05
JP6449364B2 (ja)	2019-01-09
WO2014105672A1 (en)	2014-07-03
CL2015001562A1 (es)	2016-06-24
TW201438732A (zh)	2014-10-16
BR112015012711A2 (pt)	2017-07-11
CA2896298C (en)	2024-01-16
AU2013370983B2 (en)	2019-09-26
BR112015012711B1 (pt)	2022-08-16
US10512680B2 (en)	2019-12-24
EP2938747A1 (en)	2015-11-04
KR102153275B1 (ko)	2020-09-09
US9273281B2 (en)	2016-03-01
EA032772B1 (ru)	2019-07-31
TW201832777A (zh)	2018-09-16
MX384875B (es)	2025-03-14
CN104968365B (zh)	2018-04-03
EP2938747B1 (en)	2019-05-01
CN108379571A (zh)	2018-08-10
MX2015007730A (es)	2015-09-07
JP2017145253A (ja)	2017-08-24
JP2016508983A (ja)	2016-03-24
MY173223A (en)	2020-01-07
JP6122146B2 (ja)	2017-04-26
CA2896298A1 (en)	2014-07-03
TWI660736B (zh)	2019-06-01
MX361273B (es)	2018-12-03
TWI618542B (zh)	2018-03-21
CN104968365A (zh)	2015-10-07

Publication	Publication Date	Title
NO2023020I1 (no)	2023-05-03	Retalimab - forlenget SPC
DK3225604T3 (da)	2019-06-17	Fremgangsmåde til fremstilling af flerlagsruder
DK3725778T3 (da)	2021-09-20	Formuleringer af enzalutamid
DK3079836T3 (da)	2020-01-06	Fremgangsmåder til fremstilling af effektlag
BR302012005979S1 (pt)	2014-10-29	Configuração aplicada a cadeira
BR302012005254S1 (pt)	2013-10-08	Configuracao aplicada a autoinjetor
FR2993758B1 (fr)	2015-03-27	Chaussure a semelage ameliore
EP2912485A4 (en)	2015-11-11	POSITIONING
DK2623288T3 (da)	2019-07-29	Fremgangsmåde til fremstilling af formstøbte skumdele
DK2885395T3 (da)	2020-11-30	Fremgangsmåde til frysetørring af et bakterieholdigt koncentrat
DK2708147T3 (da)	2020-05-18	Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
DK2992550T3 (da)	2019-07-22	Fremgangsmåde til fremstilling af et lab-on-a-chip
DK2932241T3 (da)	2021-07-05	Fremgangsmåde til autentificering af et ur
BR112014005756A2 (pt)	2017-03-28	vacina
JP2012186158A5 (ja)	2015-03-19	製造装置
DK2893781T3 (da)	2021-07-26	Fremgangsmåde til fremstilling af fleksible kredsløb
DK2809782T3 (da)	2017-11-20	Forbedret fremgangsmåde til fremstilling af makrokugler
DK2732707T3 (da)	2016-02-08	Fremgangsmåde til fremstilling af en sammensætning indeholdende caseinomacropeptid
IL235972B (en)	2019-10-31	Composition for preventing headaches
PT2890272T (pt)	2019-03-28	Armário, método para fabricar um armário
DK2872536T3 (da)	2019-11-25	Fremgangsmåde til ekstraktion af biomasse
DK3287518T3 (da)	2022-02-21	Fremgangsmåde til frysetørring af et bakterieholdigt koncentrat
EP2650084C0 (en)	2023-09-13	TURBINE
BR302012005252S1 (pt)	2014-06-17	Configuração aplicada a projetor
DK3047025T3 (da)	2019-06-24	Fremgangsmåde til fremstilling af kappevira